The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
EIEBFLA
4 other identifiers
interventional
12,000
1 country
1
Brief Summary
Epidural analgesia is associated with maternal intra-partum fever during labor. Intermittent epidural injections appear to reduce the incidence of maternal intra-partum fever compared to continuous epidural infusion during labor analgesia. However, the optimal combination of bolus volume and administrating interval has not yet been compared. The purpose of this prospective, randomized, double-blind trial was to determine how intermittent epidural bolus reduced the incidence of maternal intra-partum fever compared with continuous epidural infusion during labor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 7, 2012
CompletedFirst Posted
Study publicly available on registry
October 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedJanuary 15, 2015
January 1, 2015
2.7 years
October 7, 2012
January 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maternal oral and tympanic temperature
At time of initiation of analgesia and hourly thereafter until 4 hours postpartum (approximately 12 hours)
Secondary Outcomes (38)
Maternal serum Interleukin-1β
At time of placental delivery and 3, 6 and 12 hours later
Cord serum Interleukin-1β
At time of placental delivery
Maternal serum Interleukin-6
At time of placental delivery and 3, 6 and 12 hours later
Cord serum Interleukin-6
At time of placental delivery
Maternal serum Interleukin-10
At time of placental delivery and 3, 6 and 12 hours later
- +33 more secondary outcomes
Study Arms (8)
1
ACTIVE COMPARATOREpidural analgesia (EA) with continuous epidural infusion(CEI)
2
ACTIVE COMPARATORCombined spinal-epidural analgesia (CSEA) with continuous epidural infusion(CEI)
3
ACTIVE COMPARATOREpidural analgesia (EA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)
4
ACTIVE COMPARATOREpidural analgesia (EA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)
5
ACTIVE COMPARATOREpidural analgesia (EA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)
6
ACTIVE COMPARATORCombined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)
7
ACTIVE COMPARATORCombined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)
8
ACTIVE COMPARATORCombined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)
Interventions
Eligibility Criteria
You may qualify if:
- Nulliparous women
- Required labor analgesia
- Chinese
- Spontaneous labor
You may not qualify if:
- Contraindications for epidural analgesia
- Allergic to opioids and/or local anesthetics
- Failed to performing epidural catheterization
- Organic dysfunction
- Those who were not willing to or could not finish the whole study at any time
- Using or used in the past 14 days of the monoamine oxidase inhibitors
- Alcohol addictive or narcotic dependent patients
- Subjects with a nonvertex presentation or scheduled induction of labor
- Twin gestation and breech presentation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University
Nanjing, Jiangsu, 210004, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shanwu Feng, M.D.
Nanjing Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Department of Anesthesiology, Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China, 210004
Study Record Dates
First Submitted
October 7, 2012
First Posted
October 17, 2012
Study Start
October 1, 2012
Primary Completion
July 1, 2015
Study Completion
June 1, 2017
Last Updated
January 15, 2015
Record last verified: 2015-01